InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+21.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by KAHN BARBARA, Director. Insider active across 1 company, notably DEXCOM INC. Aggregated, 6 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €38k. History available since 20 May 2021. The latest transaction was filed on 18 May 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
2,927 shares0Common StockSEC:0001093557-24-000096:0
2,927 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000137:0
918 shares0Common StockSEC:0001093557-22-000119:0
100 shares@ US$428.550.0001% mcap100.0% of flowCommon StockSEC:0001093557-22-000016:0
787 shares0Common StockSEC:0001093557-21-000145:0
787 shares0Common StockSEC:0001093557-21-000145
6 of 6 declarations
About KAHN BARBARA
Barbara Kahn is a Director at Dexcom Inc. As a board member, she contributes to the governance of the company and strategic decision-making. Her expertise in the healthcare sector is an asset for Dexcom.
